tiprankstipranks
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
US Market
RANI
Rani Therapeutics Holdings
RESEARCH TOOLSreports
Want to see RANI full AI Analyst Report?

Rani Therapeutics Holdings (RANI) Income Statement

1,530 Followers

Rani Therapeutics Holdings Income Statement

Last quarter (Q4 2025), Rani Therapeutics Holdings's total revenue was $1.46M, an increase of 749.42% from the same quarter last year. In Q4, Rani Therapeutics Holdings's net income was $-10.31M. See Rani Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 1.63M$ 1.03M$ 0.00$ 0.00$ 2.72M
Gross Profit
$ 733.00K$ 1.03M$ -822.00K$ 0.00$ 2.72M
Operating Expenses
$ 39.04M$ 54.34M$ 65.28M$ 63.45M$ 54.32M
Depreciation and Amortization
$ 900.00K$ 1.03M$ 822.00K$ 548.00K$ 497.00K
EBITDA
$ -37.41M$ -50.52M$ -65.28M$ -61.66M$ -52.08M
Operating Income
$ -38.31M$ -53.31M$ -66.10M$ -63.45M$ -51.60M
Other Income/Expenses
$ -2.64M$ 23.30M$ -1.78M$ 177.00K$ -1.45M
Pretax Income
$ -40.95M$ -30.02M$ -67.88M$ -63.27M$ -53.05M
Net Income
$ -29.67M$ -30.02M$ -33.97M$ -30.59M$ -8.33M
Per Share Metrics
Basic EPS
$ -0.45$ -1.05$ -1.33$ -1.28$ -0.42
Diluted EPS
$ -0.45$ -1.05$ -1.33$ -1.28$ -0.42
Weighted Average Shares Outstanding
 66.14M 28.48M 25.50M 23.82M 19.53M
Weighted Average Shares Outstanding (Diluted)
 66.14M 28.48M 25.50M 23.82M 19.53M
Currency in USD

Rani Therapeutics Holdings Earnings and Revenue History